KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Capital Employed (2016 - 2026)

Abbott Laboratories' Return on Capital Employed history spans 18 years, with the latest figure at 9.61% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 81.0% to 9.61% in Q1 2026 year-over-year; TTM through Mar 2026 was 9.61%, a 81.0% decrease, with the full-year FY2025 number at 11.92%, up 111.0% from a year prior.
  • Return on Capital Employed hit 9.61% in Q1 2026 for Abbott Laboratories, down from 11.68% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ABT hit a ceiling of 37.41% in Q4 2022 and a floor of 9.61% in Q1 2026.
  • Historically, Return on Capital Employed has averaged 15.34% across 5 years, with a median of 11.01% in 2023.
  • Biggest five-year swings in Return on Capital Employed: surged 669bps in 2022 and later crashed -2639bps in 2023.
  • Tracing ABT's Return on Capital Employed over 5 years: stood at 37.41% in 2022, then crashed by -71bps to 11.01% in 2023, then dropped by -3bps to 10.71% in 2024, then increased by 9bps to 11.68% in 2025, then dropped by -18bps to 9.61% in 2026.
  • Business Quant data shows Return on Capital Employed for ABT at 9.61% in Q1 2026, 11.68% in Q4 2025, and 11.1% in Q3 2025.